Search Results: Displaying all items (10)

First Author Title Journal Publication Date
Haukaas FS. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis. The European journal of health economics : HEPAC : health economics in prevention and care 2016
Iqbal AZ. Cost-effectiveness of Using Quantiferon Gold (QFT-G)(®) versus Tuberculin Skin Test (TST) among U.S. and Foreign Born Populations at a Public Health Department Clinic with a Low Prevalence of Tuberculosis. Public health nursing (Boston, Mass.) 2013
Kowada A. Cost effectiveness of interferon-γ release assay for TB screening of HIV positive pregnant women in low TB incidence countries. The Journal of infection 2013
Pareek M. Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis. Thorax 2012
Nienhaus A. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC health services research 2011
Pareek M. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. The Lancet infectious diseases 2011
Horsburgh CR. Clinical practice. Latent tuberculosis infection in the United States. The New England journal of medicine 2011
Hardy AB. Cost effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the Quantiferon-TB gold IGRA alone is more cost effective for immigrants from high burden countries. Thorax 2009
Diel R. Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany. Respiratory medicine 2009
Sohn H. TB diagnostic tests: how do we figure out their costs? Expert review of anti-infective therapy 2009